SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,031 Cr | ₹2,254 Cr | ₹2,110 Cr | ₹1,967 Cr | ₹1,576 Cr |
What is the latest Total Liabilities ratio of SUVEN PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,031 Cr |
| Mar2024 | ₹2,254 Cr |
| Mar2023 | ₹2,110 Cr |
| Mar2022 | ₹1,967 Cr |
| Mar2021 | ₹1,576 Cr |
How is Total Liabilities of SUVEN PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,031 Cr | 34.47 | |
| Mar2024 | ₹2,254 Cr | 6.83 | |
| Mar2023 | ₹2,110 Cr | 7.28 | |
| Mar2022 | ₹1,967 Cr | 24.78 | |
| Mar2021 | ₹1,576 Cr | - | |
Compare Total Liabilities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹11,713.3 Cr | -13.4% | -28.1% | -71.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.5% | 1.8% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,363.0 Cr | -0.3% | -1.3% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 4.4% | 6% | 27.7% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | 1% | -3% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | 1.1% | 8% | 3.8% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -13.4% |
-28.1% |
-71.8% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses